Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Metropolis Healthcare Limited
  6. Summary
    METROPOLIS   INE112L01020

METROPOLIS HEALTHCARE LIMITED

(METROPOLIS)
  Report
End-of-day quote NSE India Stock Exchange  -  2023-06-04
1316.85 INR   +0.42%
05/16Metropolis Healthcare Seeks Acquisitions
CI
05/16Transcript : Metropolis Healthcare Limited, Q4 2023 Earnings Call, May 17, 2023
CI
05/16Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Nse India Stock Exchange
05/30/2023 05/31/2023 06/01/2023 06/02/2023 06/05/2023 Date
1305.05 1301.15 1307.15 1311.35 1316.85 Last
107433 233397 123634 73347 143907 Volume
-0.08% -0.30% +0.46% +0.32% +0.42% Change
Estimated financial data (e)
Sales 2023 11 687 M 142 M 142 M
Net income 2023 1 493 M 18,1 M 18,1 M
Net cash position 2023 376 M 4,56 M 4,56 M
P/E ratio 2023 45,2x
Yield 2023 0,86%
Sales 2024 12 346 M 150 M 150 M
Net income 2024 1 643 M 19,9 M 19,9 M
Net cash position 2024 1 460 M 17,7 M 17,7 M
P/E ratio 2024 41,3x
Yield 2024 0,83%
Capitalization 67 437 M 817 M 817 M
EV / Sales 2023 5,74x
EV / Sales 2024 5,34x
Nbr of Employees 4 532
Free-Float 46,9%
More Financials
Company
Metropolis Healthcare Limited is an India-based diagnostics company that operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical... 
Read more
More about the company
Ratings of Metropolis Healthcare Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about METROPOLIS HEALTHCARE LIMITED
05/16Metropolis Healthcare Seeks Acquisitions
CI
05/16Transcript : Metropolis Healthcare Limited, Q4 2023 Earnings Call, May 17, 20..
CI
05/16Metropolis Healthcare Limited Reports Earnings Results for the Fourth Quarter and Full ..
CI
05/11India's Dr. Lal PathLabs reports decline in Q4 profit
RE
04/01Metropolis Healthcare Limited Approves Reconstitution of Board Committees
CI
02/13Metropolis Healthcare's Consolidated Profit Slides in Fiscal Q3; EPS, Revenue Miss Esti..
MT
02/12Transcript : Metropolis Healthcare Limited, Q3 2023 Earnings Call, Feb 13, 20..
CI
02/10Metropolis Healthcare Limited Declares Interim Dividend for the Financial Year 2022-23
CI
02/10Metropolis Healthcare Limited Reports Earnings Results for the Third Quarter and Nine M..
CI
2022Metropolis Healthcare Appoints New CFO
MT
2022Surendran Chemmenkotil to Join Metropolis Healthcare Limited as Chief Executive Officer..
CI
2022Metropolis Healthcare Limited Announces Executive Changes
CI
2022INDIA STOCKS-Indian shares seen opening higher; hawkish Fed may keep lid on gains
RE
2022Metropolis Healthcare's Profit Slides in Fiscal Q2; Shares Drop 6%
MT
2022Transcript : Metropolis Healthcare Limited, Q2 2023 Earnings Call, Nov 09, 20..
CI
More news
News in other languages on METROPOLIS HEALTHCARE LIMITED
05/16Metropolis Healthcare cherche à faire des acquisitions
05/16Metropolis Healthcare Limited annonce ses résultats pour le quatrième trimestre et l'ex..
05/11Lal PathLabs (Inde) : baisse des bénéfices au quatrième trimestre
04/01Metropolis Healthcare Limited approuve la reconstitution des comités du conseil d'admin..
02/13Le bénéfice consolidé de Metropolis Healthcare dégringole au troisième trimestre de l'e..
More news
Analyst Recommendations on METROPOLIS HEALTHCARE LIMITED
More recommendations
ETFs positioned on METROPOLIS HEALTHCARE LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Motilal Oswal Midcap 100 ETF - INR0.27%0.98%-India
Vanguard FTSE All-World ex-US Small-Cap ETF - USD0.01%1.86%World
Vanguard ESG Emerging Market All Cap UCITS ...0.01%1.53%-NC
Vanguard ESG Emerging Market All Cap UCITS ...0.01%1.53%-NC
Vanguard FTSE Emerging Markets ETF - USD0.01%1.25%China
More ETFs positioned on METROPOLIS HEALTHCARE LIMITED
Chart METROPOLIS HEALTHCARE LIMITED
Duration : Period :
Metropolis Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends METROPOLIS HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 14
Last Close Price 1 316,85 INR
Average target price 1 370,50 INR
Spread / Average Target 4,07%
EPS Revisions
Managers and Directors
Surendran Chemmenkotil Chief Executive Officer
Nilesh Shah President, Head-Science & Innovation
Rakesh Agarwal Chief Financial Officer
Sushil Kanubhai Shah Executive Chairman
Simmi Singh Bisht Secretary, Head-Legal & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
METROPOLIS HEALTHCARE LIMITED-0.80%815
SONIC HEALTHCARE LIMITED19.49%11 148
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.-4.85%4 817
NEOGENOMICS, INC.94.59%2 294
SYNLAB AG-23.32%2 069
DR. LAL PATHLABS LIMITED-10.85%2 027
MarketScreener: Created by Investors for Investors!
100% Free Registration
fermer